期刊文献+

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels 被引量:2

Follicular hyperandrogenism and insulin resistance in polycystic ovary syndrome patients with normal circulating testosterone levels
下载PDF
导出
摘要 Polycystic ovary syndrome(PCOS) is a common reproductive disease with high heterogeneity. The role of excess androgen in PCOS etiology remains disputed, since around 20%-50% of PCOS women do not display hyperandrogenemia. The microenvironment of the ovary critically influences follicular development. In the present study, we assessed the role of androgen in PCOS by investigating whether excessive follicular fluid androgen was present in PCOS patients with normal serum androgen levels and influenced by follicular fluid insulin resistance(IR).Follicular fluid samples of 105 women with PCOS and 105 controls were collected. Levels of steroid hormones,glucose and insulin in the follicular fluid were examined and compared with data from serum biochemistry tests. We found that 64.9%(63/97) of PCOS patients with normal serum androgen levels displayed abnormally high follicular fluid androgen level. The follicular fluid androgen level was positively correlated with follicular fluid IR within a certain range and follicular fluid estrogen-to-testosterone(E2/T) ratio was significantly reduced in these patients.These results indicated that there existed a subgroup of PCOS patients who displayed excessive follicular fluid androgen and IR despite their normal circulating testosterone(T) levels. Our study highlights the importance of ovary hyperandrogenism and IR in the etiology of PCOS. Polycystic ovary syndrome(PCOS) is a common reproductive disease with high heterogeneity. The role of excess androgen in PCOS etiology remains disputed, since around 20%-50% of PCOS women do not display hyperandrogenemia. The microenvironment of the ovary critically influences follicular development. In the present study, we assessed the role of androgen in PCOS by investigating whether excessive follicular fluid androgen was present in PCOS patients with normal serum androgen levels and influenced by follicular fluid insulin resistance(IR).Follicular fluid samples of 105 women with PCOS and 105 controls were collected. Levels of steroid hormones,glucose and insulin in the follicular fluid were examined and compared with data from serum biochemistry tests. We found that 64.9%(63/97) of PCOS patients with normal serum androgen levels displayed abnormally high follicular fluid androgen level. The follicular fluid androgen level was positively correlated with follicular fluid IR within a certain range and follicular fluid estrogen-to-testosterone(E2/T) ratio was significantly reduced in these patients.These results indicated that there existed a subgroup of PCOS patients who displayed excessive follicular fluid androgen and IR despite their normal circulating testosterone(T) levels. Our study highlights the importance of ovary hyperandrogenism and IR in the etiology of PCOS.
出处 《The Journal of Biomedical Research》 CAS CSCD 2018年第3期208-214,共7页 生物医学研究杂志(英文版)
基金 supported by the Key Project of Chinese National Programs for Fundamental Research and Development (973 Program, 2012CBA01306) the National Natural Science Foundation of China (81471429)
关键词 polycystic ovary syndrome hyperandrogenism insulin resistance follicular fluid polycystic ovary syndrome hyperandrogenism insulin resistance follicular fluid
  • 相关文献

参考文献1

二级参考文献31

  • 1Clark NM, Podolski A J, Brooks ED, et al. Prevalence of polycystic ovary syndrome phenotypes using updated cri- teria for polycystic ovarian morphology: an assessment of over 100 consecutive women self-reporting features of polycystic ovary syndrome[J]. Reprod Sci, 2014,21: 1034-1043.
  • 2Revised 2003 consensus on diagnostic criteria and long- term health risks related to polycystic ovary syndrome[J]. Fertil Steril, 2004,81 : 19-25.
  • 3Albu A, Radian S, Fica S, et al. Biochemical hyperan- drogenism is associated with metabolic syndrome inde- pendently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients[J]. Endocrine, 2014.
  • 4Epub ahead of print. Huang A, Brennan K, Azziz R. Prevalence of hyperandro- genemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria[J]. Fertil Steril, 2010,93:1938-1941.
  • 5O'Reilly MW, Taylor AE, Crabtree N J, et al. androstenedi- one[J]. J Clin Endocrinol Metab, 2014,99:1027-1036.
  • 6Voutilainen R, Jaaskelainen J. Premature adrenarche: Etiology, clinical findings, and consequences[J]. J Steroid Biochem Mol Biol, 2014.
  • 7Epub ahead of print. Demir B, Pasa S, Demir S, et al. Hirsutism score and the severity of hyperandrogenism associated with polycystic ovary syndrome in the southeastern region of Turkey[J]. J lnt Med Res, 2011,39:1529-1535.
  • 8Ozdemir S, Ozdemir M, Gorkemli H, et al. Specific der- matologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism[J]. Acta Obstet Gynecol Scand, 2010,89:199-204.
  • 9Hart R, Hickey M, Franks S. Definitions, prevalence and symp- toms of polycystic ovaries and polycystic ovary syndrome[J]. Best Pract Res Clin Obstet Gynaecol, 2004,18:671-683.
  • 10Solomon A, Norton GR, Woodiwiss A J, et al. Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross- sectional study[J]. Arthritis Res Ther, 2012,14:R67.

共引文献7

同被引文献16

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部